Ariad Pharmaceuticals, Inc. Share Price
Equities
US04033A1007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2017 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
2014 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Managers | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+21.73% | 127B | |
+24.93% | 117B | |
+26.75% | 27.77B | |
-18.30% | 20.44B | |
-14.43% | 16.62B | |
-12.04% | 15.92B | |
-46.65% | 14.94B | |
+13.04% | 14.74B | |
+56.77% | 14.38B |
- Stock Market
- Equities
- Stock